RESULTS OF CRANIOSPINAL IRRADIATION AFTER SURGERY IN MEDULLOBLASTOMA AT CHO RAY HOSPITAL
Main Article Content
Abstract
Purpose: Evaluating the results of of craniospinal irradiation after surgery in medulloblastoma at Cho Ray hospital. Materials and methods: Retrospective study of 31 surgically treated medulloblastoma patients who received craniospinal irradiation at Radiation department – Cho Ray Cancer Center from January 1, 2018 to December 31, 2023 (6 years). Results: The male/female ratio is 1.38, children ≤ 16 years old account for 67.7%. The most common tumor location is in the cerebellum (accounting for 65%), the fourth ventricle (26%). The average tumor size is 4.7 ± 0.9 cm (2.5 – 7 cm). 61% had gross total resection, 29% had near total resection, and 10% had partial resection. Median PFS was 53.4 ± 5.7 months, 1-year PFS was 83.4%, 2-year was 70.8%, 3-year was 66.1%, 4-year was 60.6%, and 5-year was 60 .6%. Median OS was 58 ± 5.3 months, 1-year OS was 90.1%, 2-year was 74.3%, 3-year was 69.3%, 4-year was 69.3% and 5-year was 69.3%. The difference between gross total resection and near total resection is not statistically significant in both PFS and OS. The difference is statistically significant when compared to partial resection (p=0.001). Conclusion: Combining surgery and post-operative craniospinal irradiation brings very positive results in the treatment of medulloblastoma.
Article Details
Keywords
medulloblastoma, craniospinal irradiation
References

2. Khanna V. et al. (2017) Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. Journal of neuro-oncology, 135: p. 433-441.

3. Phạm Thanh Tuân, Kiều Đình Hùng, Phạm Cẩm Phương. (2023). Đặc điểm lâm sàng, kết quả điều trị phẫu thuật và xạ trị gia tốc u nguyên bào tủy tại bệnh viện Việt Đức. Tạp chí y học Việt Nam, Tập 528, tháng 7, số 2: p. 190-195.

4. Nalita N. et al. (2018). Survival and prognostic factors in pediatric patients with medulloblastoma in Southern Thailand. Journal of Pediatric Neurosciences, 13(2): p. 150-157.

5. Seidel C. et al. (2021). Radiotherapy in medulloblastoma—evolution of treatment, current concepts and future perspectives. Cancers, 13(23): p. 5945.

6. Tandian D. et al. (2021). Risk factors associated with post-therapeutic outcome for medulloblastoma: An experience from Indonesia. Asian Journal of Neurosurgery, 16(03): p. 494-499.

7. Thompson E.M. et al. (2016). Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. The lancet oncology, 17(4): p. 484-495.
